Skip to content

Cholestatic liver diseases in children: a prospective cohort study

Cholestatic liver diseases in children: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015717
Enrollment
Unknown
Registered
2018-04-16
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholestatic liver diseases

Interventions

2:Medince

Sponsors

GuangZhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. bilirubin standard: total bilirubin (TBil) 17umol/L; Or TBil>85umol/L, the proportion of DBil in TBil is > 20%; 2. aged standard: patients aged 0-18 years, who have been enrolled in infancy, are not restricted during the follow-up period; 3. disease name standard: possible application in the medical diagnosis include jaundice, cholestasis, cholestasis, liver syndrome baby, infant hepatitis syndrome, neonatal hepatitis syndrome, bile thick, biliary atresia and common bile duct cyst, etc.

Exclusion criteria

Exclusion criteria: 1. cholecystolithiasis combined with cholecystitis, bile duct stones combined with cholangitis, liver cancer, traumatic biliary obstruction, iatrogenic biliary obstruction and postoperative status of liver transplantation; 2. other conditions that are not suitable for inclusion in clinical practice; 3. no informed consent has been obtained.

Design outcomes

Primary

MeasureTime frame
bilirubin;

Countries

China

Contacts

Public ContactHuimin Xia

GuangZhou Women and Children's Medical Center

xia-huimin@foxmail.com+86 020-38076147

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026